Table 1. The correlations between BRSK2 and clinical pathological parameters in PDAC.
| None | Weak | Moderate | Strong | p | ||
|---|---|---|---|---|---|---|
| Gender | Male | 3 | 10 | 20 | 34 | R=-0.012p>0.05 |
| Female | 0 | 9 | 12 | 14 | ||
| Age | <60 | 2 | 5 | 15 | 18 | R=-0.061p>0.05 |
| >60 | 1 | 14 | 17 | 30 | ||
| Tumor location | Head | 2 | 18 | 25 | 30 | R=0.260P=0.008 |
| Body-tail | 1 | 1 | 6 | 13 | ||
| Entire | 0 | 0 | 1 | 5 | ||
| Tumor stage | Tis+T1+T2 | 1 | 5 | 8 | 7 | R=0.143P=0.156 |
| T3+T4 | 2 | 14 | 23 | 41 | ||
| Regional lymph status | N.A | 0 | 1 | 5 | 13 | R=-0.166p>0.05 |
| No | 3 | 8 | 8 | 19 | ||
| Yes | 0 | 10 | 19 | 16 | ||
| Distant metastases | No | 3 | 18 | 28 | 46 | R=-0.052p>0.05 |
| Yes | 0 | 1 | 4 | 2 | ||
| Nerve invasion | No | 2 | 9 | 9 | 7 | R=0.340P=0.002 |
| Yes | 1 | 10 | 23 | 41 | ||
| Vascular invasion | No | 2 | 14 | 23 | 25 | R=0.196P=0.050 |
| Yes | 1 | 5 | 9 | 23 | ||
| Living status | lost | 0 | 6 | 8 | 15 | Log rank:p>0.05 |
| live | 1 | 2 | 5 | 4 | ||
| die | 2 | 11 | 19 | 29 |